Projects per year
Abstract
N-aryl-oxazolidinones is a prominent family of antimicrobials used for treating infections caused by clinically prevalent Gram-positive bacteria. Recently, boron-containing compounds have displayed intriguing potential in the antibiotic discovery setting. Herein, we report the unprecedented introduction of a boron-containing moiety such as an aryl boronic acid in the external region of the oxazolidinone structure via a chemoselective acyl coupling reaction. As a result, we accessed a series of analogues with a distal aryl boronic pharmacophore on the oxazolidinone scaffold. We identified that a peripheric linear conformation coupled with freedom of rotation and no further substitution on the external aryl boronic ring, an amido linkage with hydrogen bonding character, in addition to a para-relative disposition between boronic group and linker, are the optimal combination of structural features in this series for antimicrobial activity. In comparison to linezolid, the analogue comprising all those features, compound 20b, displayed levels of antimicrobial activity augmented by an eight-fold to a thirty-two-fold against a panel of Gram-positive strains, and a near one hundred-fold against Escherichia coli JW5503, a Gram-negative mutant strain with a defective efflux capability.
Original language | English |
---|---|
Article number | 113002 |
Journal | European Journal of Medicinal Chemistry |
Volume | 211 |
Number of pages | 8 |
ISSN | 0223-5234 |
DOIs | |
Publication status | Published - 5 Feb 2021 |
MoE publication type | A1 Journal article-refereed |
Fields of Science
- 114 Physical sciences
- oxazolidinone antibiotics
- BORON
- BORONIC ACIDS
- 317 Pharmacy
- Gram-positive bacteria
- Gram-Negative Bacteria
- efflux pumps
- ANTIMICROBIAL ACTIVITY
- Oxazolidinone antibiotics
- Boron
- Boronic acid
- Gram-positive bacteria
- Gram-negative bacteria
- Efflux pumps
- Antimicrobial activity
- OXAZOLIDINONE ANTIBACTERIAL AGENTS
- DISCOVERY
- DESIGN
- ANTIBIOTICS
- IDENTIFICATION
- CHALLENGES
- INHIBITORS
- EFFLUX
- RING
- SITE
Projects
- 1 Finished
-
NO-ESCAPE: Evolving the next generation of Gram-negative antimicrobials through a synergetic approach encompassing medicinal chemistry, microbiology and nanomedicine tools
Ilina, P. (Participant), Yashin, V. (Participant), Wrigstedt, P. (Participant), Durante Cruz, C. (Participant), Perea-Buceta, J. E. (Co-Principal Investigator) & Tammela, P. (Project manager)
Suomen Akatemia Projektilaskutus
01/09/2019 → 31/08/2023
Project: Research project